SCM
BSX icon

Saba Capital Management’s Boston Scientific BSX Stock Holding History

Saba Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-410,000
Closed -$20.5M – 637
2023
Q1 		$20.5M Sell
410,000
-500,000
-55% -$23.6M 0.39% 53
2022
Q4 		$42.1M Hold
910,000
– – 0.57% 18
2022
Q3 		$35.2M Buy
910,000
+410,000
+82% +$16.4M 0.4% 20
2022
Q2 		$18.6M Buy
+500,000
New +$20.4M 0.22% 105

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Saba Capital Management's BSX Position: Q2 2023 in Review

Saba Capital Management sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 4,730 shares — an estimated $237K sold.

Saba Capital Management first reported a position in BSX in Q2 2022 and held it in 4 quarters. The position peaked at $15.6M in Q3 2022. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Saba Capital Management reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Saba Capital Management sold 4,730 Boston Scientific shares in Q2 2023, an estimated $237K.
  • Saba Capital Management first reported a position in Boston Scientific in Q2 2022 and held it in 4 quarters.
  • Saba Capital Management's Boston Scientific position peaked at $15.6M in Q3 2022.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Saba Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.